| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/28/1999 | CN1214924A Traditional Chinese medicine chewing gum with moistening lung function |
| 04/28/1999 | CN1214907A Citrate concentrate and preparation process thereof |
| 04/28/1999 | CN1214906A Multi-functional ointment for injuries |
| 04/28/1999 | CA2252156A1 Enhancer tolerant pressure sensitive adhesive composition for transdermal drug delivery |
| 04/27/1999 | US5898040 Microporous polymeric foams and microtextured surfaces |
| 04/27/1999 | US5898034 Psoriasis medication and application for remission and/or cure of plaque psoriasis |
| 04/27/1999 | US5898028 An antidiabetic agent in the form of powder suitable for pulmonary administeration comprises particles of insulin or derivative, an enhancer for insulin absorption is selected from fatty acid salt, bile salt, and a phospholipid |
| 04/27/1999 | US5897910 Production of covered tablets |
| 04/27/1999 | US5897897 Glassy matrix of a modified starch and a propylene glycol or glycerin which is stable at ambient temperatures, noncaking, and has a high glass transition temperature to prevent plastic flow; encapsulation of flavoring agents, for example |
| 04/27/1999 | US5897880 Topical drug preparations |
| 04/27/1999 | US5897879 Sustained-release pharmaceutical system for the delivery of antioxidants |
| 04/27/1999 | US5897878 Method for administering steroid |
| 04/27/1999 | US5897877 Pellets coated with a polymer resistant to the stomach's gastric juice, and containing an acid salt, such as potassium dihydrogen phosphate, a separating agent, and a softening agent; quick release into intestinal tract |
| 04/27/1999 | US5897876 A water-in-oil emulsion comprising a continuous hydrophobic phase and a discontinuous aqueous hydrophilic phase, surfactant dispersants and active drug for oral delivery |
| 04/27/1999 | US5897874 Expulsion of material from a delivery device |
| 04/27/1999 | US5897873 Affinity associated vaccine |
| 04/27/1999 | US5897872 Iodine-containing nasal moisturizing saline solution |
| 04/27/1999 | US5897871 Therapeutic agent for the treatment of melanomas |
| 04/27/1999 | US5897858 Nasal spray compositions exhibiting increased retention in the nasal cavity |
| 04/27/1999 | US5897852 Container having vaccine components present in freeze dried bodies, at least one having single vaccine component, and at least one being lyosphere |
| 04/27/1999 | US5897539 Hormone replacement therapy method and hormone dispenser |
| 04/27/1999 | CA2251277A1 Intra-articular preparation for the treatment of arthropathy |
| 04/27/1999 | CA2250524A1 Effervescent formulation containing plant extract |
| 04/27/1999 | CA2134987C Substained release alginate fibre and process for the preparation thereof |
| 04/27/1999 | CA2132144C Oil in water stable emulsions and compositions containing them |
| 04/27/1999 | CA2129635C Method of ophthalmic drug delivery |
| 04/27/1999 | CA2127581C Process for preparing spherules |
| 04/27/1999 | CA2117726C Oil-in-water emulsion for the preparation of a cream |
| 04/27/1999 | CA2111085C Extended-release form of diltiazem |
| 04/27/1999 | CA2105079C Composition and method for delivery of drugs |
| 04/27/1999 | CA2097182C Method and device for treating tobacco addiction |
| 04/27/1999 | CA2096036C Method for stimulating intracellular synthesis of glutathione using esters of l-2-oxothiazolidine-4-carboxylate |
| 04/27/1999 | CA2059523C Pharmaceutical compositions |
| 04/27/1999 | CA2058959C A fructose-based granulated product and a process for the production th ereof |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999018998A2 Delivery system |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018994A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018978A1 Bovine teat dip |
| 04/22/1999 | WO1999018977A1 Readily absorbable phytosterol glycosides to treat hypercholesterolemia |
| 04/22/1999 | WO1999018971A1 Mometasone furoate suspensions for nebulization |
| 04/22/1999 | WO1999018970A1 Preventives and remedies for ophthalmic circulatory disturbance |
| 04/22/1999 | WO1999018967A1 Analgesic compositions |
| 04/22/1999 | WO1999018966A1 Parenteral formulations comprising carbamazepine or its derivatives |
| 04/22/1999 | WO1999018965A1 Oral compositions containing a cephalosporin antibiotic |
| 04/22/1999 | WO1999018963A1 Use of flunarizine for the topical treatment of glaucoma |
| 04/22/1999 | WO1999018955A1 Percutaneously absorbable preparation |
| 04/22/1999 | WO1999018950A1 Mixed cyanoacrylate ester compositions |
| 04/22/1999 | WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | WO1999018940A1 Malodor counteractant compositions and methods for preparing and using same |
| 04/22/1999 | WO1999018939A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 04/22/1999 | WO1999018938A1 Delayed total release gastrointestinal drug delivery system |
| 04/22/1999 | WO1999018937A1 New cyclobenzaprine composition |
| 04/22/1999 | WO1999018936A1 Quickly soluble solid preparations |
| 04/22/1999 | WO1999018935A1 Preparation of a directly mouldable tabletting auxiliary |
| 04/22/1999 | WO1999018934A1 Micro-particulate and nano-particulate polymeric delivery system |
| 04/22/1999 | WO1999018933A2 Methods for encapsulating nucleic acids in lipid bilayers |
| 04/22/1999 | WO1999018932A1 Novel once-a-day controlled release sulfonylurea formulation |
| 04/22/1999 | WO1999018930A2 Pharmaceutical preparations |
| 04/22/1999 | WO1999018923A1 Reducing agent with several constituents comprising at least a composition in powder form containing an agent for reducing hair sulphur bonds and method for permanent setting of keratin fibres |
| 04/22/1999 | WO1999018918A1 Water dispersible perfluoroether polymer encapsulates |
| 04/22/1999 | WO1999018892A1 Biodegradable, biopolymeric bioelectret implant for tissue regeneration |
| 04/22/1999 | WO1999018884A1 Drug delivery system |
| 04/22/1999 | WO1999018798A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/22/1999 | WO1999018797A1 Method and devices for transdermal delivery of lithium |
| 04/22/1999 | WO1999013886B1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 04/22/1999 | WO1999013717B1 A delivery of arginine to cause beneficial effects |
| 04/22/1999 | WO1999006035A3 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 04/22/1999 | WO1999006011A3 Shellac-containing cosmetic product |
| 04/22/1999 | WO1999004767A3 Osmotic delivery system with semipermeable plug |
| 04/22/1999 | WO1999003454A9 Biodegradable macromers for the controlled release of biologically active substances |
| 04/22/1999 | WO1998044021A9 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 04/22/1999 | WO1998043618A9 Use of cytoskeletal inhibitors for the prevention of restenosis |
| 04/22/1999 | WO1998030203A3 Transdermal therapeutic system |
| 04/22/1999 | WO1998029085A3 Skin product having continuing antimicrobial, antiviral, antiseptic, and healing properties |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | DE19847781A1 Pharmaceutical preparations containing PETN or metabolite useful in treatment of cardiac, circulatory, and cerebrovascular disorders |
| 04/22/1999 | DE19845339A1 Directly compressible tabletting aid |
| 04/22/1999 | DE19746432A1 Emulsifying plant extracts in cold pressed olive oil using mixing mill with structured rotating disks and magnets in hermetically sealed mixing vessel |
| 04/22/1999 | DE19746173A1 Tumor vaccine based on tumor antigens comprises a slow-release system of gamma-interferon (IFN-gamma |
| 04/22/1999 | DE19745950A1 Drug carrier particle for site specific drug delivery, especially to CNS |
| 04/22/1999 | DE19745712A1 New composition for treating sickle cell disease |
| 04/22/1999 | CA2792406A1 Methods for encapsulating nucleic acids in lipid bilayers |
| 04/22/1999 | CA2308489A1 Method and devices for transdermal delivery of lithium |
| 04/22/1999 | CA2308055A1 Malodor counteractant compositions and methods for preparing and using same |
| 04/22/1999 | CA2307208A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/22/1999 | CA2306479A1 Percutaneously absorbable preparation |
| 04/22/1999 | CA2306206A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | CA2306096A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 04/22/1999 | CA2305756A1 Rapidly dissolving solid preparation |
| 04/22/1999 | CA2304457A1 Mixed cyanoacrylate ester compositions |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909562A1 Injections containing lipid a analogues and process for the preparation thereof |
| 04/21/1999 | EP0909558A2 Chroman derivative containing ophthalmic solution |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909177A1 Aqueous formulations of peptides |
| 04/21/1999 | EP0909175A1 Non-aqueous protic peptide formulations |
| 04/21/1999 | EP0909173A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 04/21/1999 | EP0909168A2 Propellant mixtures and aerosols for micronising medicaments with compressed gas |